Favourites   Have ideas?

Positive:   Disease: Oncology ↓8.54   Cannabis ↓8.54   Disease: Leukemia ↓6.45 «See more»   Biopharma ↑11.82   Animals ↑45.43   Pets ↑45.43

Negative:


Biotechnology segment

ACOR TR» TW» GGL» QAcorda Therapeutics, Inc. - Common Stock + My List -3.19% down 9.2% -12.39 + Disease: Neurology/Alzheimer/Parkinson's, Medicine, Biotechnology


Last highlighted: Form 8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain.. $ACOR https://t.co/pzylSpmKBK
APTO TR» TW» GGL» SAptose Biosciences, Inc. - Common Shares + My List -8.24% up -9.88% 1.64 + Biotechnology

BNTC TR» TW» GGL» SBenitec Biopharma Inc. - Common Stock + My List 0.91% up -7.02% 7.93 + Biopharma, Biotechnology, RNA, Medicine, Gene and cell


Last highlighted: Form 8-K: Regulation FD Disclosure. On February 24, 2021, Benitec Biopharma issued a presentation on the results of the interim analysis.. $BNTC https://t.co/mayyXsnb9Q
BNTX TR» TW» GGL» QBioNTech SE - American Depositary Shares + My List -6.08% up -7.09% 1.01 + Biotechnology, Immunology, Covid (fighting), Medicine

ENTX TR» TW» GGL» SEntera Bio Ltd. - Ordinary Shares + My List 11.71% up 2.68% 9.03 + Country: Israel, Biotechnology, Pharmaceutical


Last highlighted: $ENTX 📜 SEC Form 6-K filed by Entera Bio Ltd. https://t.co/dws8IKVGAV #healthcare
FBIOP TR» TW» GGL» SFortress Biotech, Inc. - 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock + My List up -8.08% 8.08 + Medicine, Biotechnology, Biopharma

FLDM TR» TW» GGL» QFluidigm Corporation - Common Stock + My List -9.14% -9.14% 0 + Life Sciences, Biology, Cancer fight, Biotechnology, RNA


Last highlighted: Fluidigm Corporation 2021 Q1 - Results - Earnings Call Presentation
FRLN TR» TW» GGL» QFreeline Therapeutics Holdings plc - ADSs + My List -8.12% -8.12% 0 + Medicine, Biotechnology, Gene and cell

GLYC TR» TW» GGL» GGlycoMimetics, Inc. - Common Stock + My List -6.45% up -7.53% 1.08 + Biotechnology, Medicine, Disease: Leukemia

IGMS TR» TW» GGL» QIGM Biosciences, Inc. - Common Stock + My List -1.28% up -8.17% 6.89 + Biotechnology, Gene and cell, Medicine

IMNM TR» TW» GGL» SImmunome, Inc. - Common Stock + My List 1.14% up -7.5% 8.64 + Cancer fight, Biotechnology, Medicine, Immunology

KIN TR» TW» GGL» SKindred Biosciences, Inc. - Common Stock + My List 45.43% down 45.74% -0.31 + Animals, Biopharma, Biotechnology, Medicine, Pets


Last highlighted: Alert [Press/News Current Report] / Form 8-K filed with the SEC $KIN Kindred Biosciences, Inc https://t.co/qfUr5eJpM1
LRMR TR» TW» GGL» GLarimar Therapeutics, Inc. - Common Stock + My List -8.29% up -9.06% 0.77 + Medicine, Gene and cell, Biotechnology

MBRX TR» TW» GGL» SMoleculin Biotech, Inc. - Common Stock + My List 6.57% down 7.14% -0.57 + Biotechnology, Pharmaceutical , Medicine, Cancer fight, Disease: Infectious


Last highlighted: A Form 8-K [Press/News Current Report] filing has been made with the SEC: $MBRX Moleculin Biotech, Inc https://t.co/Vf4o3Jd0I1
MCRB TR» TW» GGL» QSeres Therapeutics, Inc. - Common Stock + My List 5.67% down 8.99% -3.32 + Medicine, Microbiome, Biotechnology

NRIX TR» TW» GGL» GNurix Therapeutics, Inc. - Common stock + My List 13.33% up 12.58% 0.75 + Biotechnology, Cancer fight, Immunology


Last highlighted: $NRIX 📜 Nurix Therapeutics, Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits https://t.co/L9Q0b3aMu8 #majorpharmaceuticals #healthcare
NTLA TR» TW» GGL» GIntellia Therapeutics, Inc. - Common Stock + My List 0.94% up -10.34% 11.28 + Medicine, Gene and cell, Biotechnology, Biopharma

ONCR TR» TW» GGL» GOncorus, Inc. - Common Stock + My List up -8.01% 8.01 + Cancer fight, Immunology, Biotechnology

ORGS TR» TW» GGL» SOrgenesis Inc. - Common Stock + My List down 7.32% -7.32 + Biotechnology, Medicine, Gene and cell


Last highlighted: Filing Alert, FORM 10-Q [Quarterly Report] available. $ORGS #Orgenesis Inc. Orgenesis Inc https://t.co/cwDFhLgUnk
PRQR TR» TW» GGL» GProQR Therapeutics N.V. - Ordinary Shares + My List 0.54% down 9.37% -8.83 + Medicine, Biotechnology, Disease: Eye , RNA

QRVO TR» TW» GGL» QQorvo, Inc. - Common Stock + My List -1.4% up -8.69% 7.29 + Semiconductor, Biotechnology, Diagnosing, IoT, 5G, Mobile, Network Infrastructure, Equipment

RGNX TR» TW» GGL» QREGENXBIO Inc. - Common Stock + My List 5.51% down 8.27% -2.76 + Gene and cell, Biotechnology, Medicine

RKDA TR» TW» GGL» SArcadia Biosciences, Inc. - Common Stock + My List 7.69% up 4.76% 2.93 + Agritech, Biotechnology

SELB TR» TW» GGL» GSelecta Biosciences, Inc. - Common Stock + My List -3.13% down 8.53% -11.66 + Biotechnology, Immunology, Biology, Medicine


Last highlighted: $SELB Selecta Biosciences, Inc. SEC Filing: Form 8-K https://t.co/0XklTmmzMS
SLRX TR» TW» GGL» SSalarius Pharmaceuticals, Inc. - Common Stock + My List -12.04% down -8.38% -3.66 + Cancer fight, Biotechnology, Medicine, Pharmaceutical


Last highlighted: $SLRX 8-K Salarius Pharmaceuticals (8 Mar, 4:30pm) 📰 Salarius Announces Pricing of $20 Million Underwritten Public Offering of Common Stock https://t.co/AWdEx2wgvD #SLRX #8K #SalariusPharmaceuticals #News
TWST TR» TW» GGL» QTwist Bioscience Corporation - Common Stock + My List 7.02% 7.02% 0 + Biotechnology, RNA, Medicine

WVE TR» TW» GGL» GWave Life Sciences Ltd. - Ordinary Shares + My List 1.35% down 7.4% -6.05 + Medicine, Biotechnology, Life Sciences

YTEN TR» TW» GGL» SYield10 Bioscience, Inc. - Common Stock + My List 8.11% 8.11% 0 + Biotechnology, Agritech, Food

ENVB TR» TW» GGL» SEnveric Biosciences, Inc. - Common Stock + My List -8.54% up -9.76% 1.22 + Biotechnology, Cancer fight, Medicine, Cannabis, Disease: Oncology


Last highlighted: $ENVB 8-K Enveric Biosciences (8 Jun, 2:25pm) 📰 Regulation FD Disclosure; Financial Statements and Exhibits https://t.co/cn8oMiFBRC #ENVB #8K #EnvericBiosciences #News
GBS TR» TW» GGL» GGBS Inc. - Common Stock + My List -6.36% up -8.47% 2.11 + Medicine, Biotechnology



We do not provide financial advice. All displayed data is the result of experiments, and a subjective assessment. All decisions that will be made based on this data are made at your own risk. Thank you for understanding.